APA

Nardin E. H., Oliveira G. A., Calvo-Calle J. M., Castro Z. R., Nussenzweig R. S., Schmeckpeper B., Hall B. F., Diggs C., Bodison S. & Edelman R. (20001201). Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. : The Journal of infectious diseases.

Chicago

Nardin E H, Oliveira G A, Calvo-Calle J M, Castro Z R, Nussenzweig R S, Schmeckpeper B, Hall B F, Diggs C, Bodison S and Edelman R. 20001201. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. : The Journal of infectious diseases.

Harvard

Nardin E. H., Oliveira G. A., Calvo-Calle J. M., Castro Z. R., Nussenzweig R. S., Schmeckpeper B., Hall B. F., Diggs C., Bodison S. and Edelman R. (20001201). Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. : The Journal of infectious diseases.

MLA

Nardin E H, Oliveira G A, Calvo-Calle J M, Castro Z R, Nussenzweig R S, Schmeckpeper B, Hall B F, Diggs C, Bodison S and Edelman R. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. : The Journal of infectious diseases. 20001201.